First, Do No Harm

Pediatrics

Volumn 121, Issue 4, 2008, Pages 831-832

  Benjamin, Daniel K ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ANTIFUNGAL AGENT;

CANDIDIASIS; CAUSE OF DEATH; INCIDENCE; MORBIDITY; MORTALITY; NERVE CELL DIFFERENTIATION; NEWBORN INFECTION; NOTE; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; DEVELOPMENTAL DISORDER; DISEASE TRANSMISSION; FEMALE; HUMAN; MALE; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; RISK ASSESSMENT; SAFETY; SENSITIVITY AND SPECIFICITY; SURVIVAL; VERY LOW BIRTH WEIGHT;

ANTIFUNGAL AGENTS; CANDIDIASIS; DEVELOPMENTAL DISABILITIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; FLUCONAZOLE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK ASSESSMENT; SAFETY MANAGEMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 42949171048     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-0068     Document Type: Note

References (4)

1. Healy CM, Campbell JR, Zaccaria E, Baker CJ. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality without emergence of fluconazole-resistant candida species. Pediatrics. 2008:121(4):703-710
2. Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr. 2005;147(2):166-171
3. Cotten CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin DK Jr. The association of third generation cephalosporin use and invasive candidiasis in extremely low birth weight infants. Pediatrics. 2006;118(2):717-722
4. Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality, and neurodevelopmental outcomes at 18-22 months. Pediatrics. 2006;117(1):84-92